Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Average Recommendation of “Moderate Buy” from Brokerages
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, eight have assigned a buy recommendation and one […]
21 Aug 08:29 · The Markets Daily